Business ❯Pharmaceuticals ❯Research and Development

Investment

Boehringer Ingelheim Reports Strong 2024 Growth and Prepares for New Product Launches in 2025

AstraZeneca Announces $2.5 Billion Beijing R&D Hub to Bolster China Presence